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Colorectal cancer is rare in teenagers, especially without known risk factors. Colon cancer in young age is more likely to be diagnosed at 
advanced-stage, to present unfavorable tumor histology such as mucinous carcinoma, and poor outcome. We report a case of sporadic 
mucinous adenocarcinoma of the colon in a 19-year-old male patient without any risk factors. He complained of severe left abdominal 
pain that developed 1 month ago. He had a distended abdomen with severe tenderness on the left lower quadrant. A distal descending 
colon mass causing mechanical obstruction was observed on abdominal computed tomography. Emergency colonoscopy showed a 
large, fungating mass obstructing the lumen at 40 cm from the anal verge. Biopsy of the colonic mass suggested a mucinous adenocarci-
noma. After decompression by colonic stent, the patient was transferred to the general surgery department for left hemicolectomy. The 
lesion was confirmed to be a mucinous adenocarcinoma (7.0×4.5 cm). For hereditary nonpolyposis colorectal cancer evaluation, immu-
nohistochemical staining for MLH1 and MSH2 was normal. Reverse transcription polymerase chain reaction analysis did not detect 
microinstability in any of the markers tested. The patient had no familial history of cancer. Mucinous adenocarcinoma has high frequen-
cies of poor differentiation, advanced tumor stage, loss of mismatch repair gene expression, and increased MUC2 expression. A muci-
nous histology is considerably more frequent in children and adolescent than in adults. Adequate invasive study is also necessary for 
young age patients.
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INTRODUCTION
Colorectal cancer is rare in teenagers, especially without 
known risk factors such as inflammatory bowel disease, fa-
milial adenomatosis polyposis, and hereditary nonpolyposis 
colon cancer (HNPCC). Although the presenting features of 
colorectal carcinoma are similar between adolescents and 
adults, it is frequently overlooked in the differential diagnosis 
in young patients.
1 Many reports suggest that children are 
more likely than adults to have advanced-stage disease at pre-
sentation, unfavorable tumor histology, and poor outcome.
2
In the pathological point of view, a mucinous histology is 
considerably more frequent in children and adolescents than 
in adults. Here, we report a case of mucinous adenocarcino-
ma of the colon in a 19-year-old male patient without any risk 
factors. We also review the clinical and pathological charac-
teristics of young-age sporadic colorectal cancer (YSCC).
CASE REPORT
A 19-year-old man visited the gastroenterology outpatient 
department complaining severe left abdominal pain that de-
veloped 1 month ago. On physical examination, he was found 
to have a distended abdomen with severe tenderness on the 
left lower quadrant. An abdominal X-ray revealed a multiple 
stepladder sign (Fig. 1A). Abdominal computed tomography 
scan was then immediately performed which revealed a dis-
tal descending colon mass causing mechanical obstruction 
(Fig. 1B).
The patient had been living in Australia for his studies. He 
first felt a left-sided abdominal pain a month ago. He also had 
acute constipation and passed loose stool 1 to 2 times per 104  Clin Endosc 2012;45:103-107
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Fig. 2. Colonoscopic findings. (A) Large mass making lumenal obstruction. (B) Gushed out fecal material is seen after stent insertion.
A B
Fig. 3. Pathologic fingdings. (A) A circumferential ulceroinfiltrative tumor, 7.0×4.5 cm. (B) Submucosal invasion of mucinous adenocarcino-
ma can be seen (H&E stain, ×200).
A B
Fig. 1. Radiologic findings. (A) Multiple step-ladder sign is presented. (B) Enhancing mass (red arrow) on distal descending colon. Surround-
ing soft tissue edema and mechanical obstruction of large bowel are seen. 
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week. He visited a private clinic in Australia, and the physi-
cian gave a diagnosis of acute colitis with regard to his ab-
dominal pain and loose stool. Despite medication, he did not 
feel any symptomatic improvement so he returned to South 
Korea the previous day. 
The patient was sent to an endoscopy room, and an emer-
gency colonoscopy showed a large, fungating mass obstruct-
ing lumen at 40 cm from the anal verge. Through-the-scope 
stent insertion was performed to decompress the gastrointes-
tinal tract (Fig. 2). After stenting, a massive stool gushed out. 
No other polyp or mass was seen on the sigmoid colon and 
rectum. 
On the second hospital day, his abdominal pain markedly 
improved. His serum carcinoembryonic antigen level was 
3.85 ng/mL, and his erythrocyte sedimentation rate and C-
reactive protein level were elevated (13 mm/h and 3.31 mg/
dL, respectively). No other abnormal laboratory findings, 
such as anemia, or leukocytosis, were observed. Biopsy of the 
colonic mass suggested a mucinous adenocarcinoma. Posi-
tron emission tomography scan revealed a hypermetabolic 
lesion on the descending colon without other metastatic le-
sions. The patient was transferred to the general surgery de-
partment and was subjected to left hemicolectomy under 
general anesthesia. The pathology was confirmed as muci-
nous adenocarcinoma (7.0×4.5 cm), penetrating the visceral 
peritoneum and with one regional lymph node involvement 
out of 47 (Fig. 3). For HNPCC evaluation, immunohisto-
chemical staining for MLH1 and MSH2 was done, which 
gave a normal result. RT-PCR analysis did not detect micro-
instability in any of the markers tested (Fig. 4). The patient 
had no family history of cancer, including his parents, grand-
parents, and cousins (Fig. 5). He was discharged after surgery 
without any events. He was transferred to other hospital for 
adjuvant chemotherapy according to his family’s decision.
DISCUSSION
Colorectal carcinoma rarely occurs in children and adoles-
cents. It is generally considered to be a disease of older per-
sons; more than 90% of colorectal cancer patients is above 55 
years old.
3 Groups of young patients known to be at increased 
risk for colorectal carcinoma are those with inflammatory 
bowel disease, HNPCC, and polyposis syndromes of the gas-
trointestinal tract.
4 APC gene mutations produce classic or at-
tenuated familial polyposis coli. 
Mutations in mismatch repair (MMR) genes, principally 
MSH2 and MLH1 but also PMS1 and PMS2, cause HNPCC.
5 
Fig. 4. Reverse transcription polymerase chain reaction of micro-
satellite instability marker shows microsatellite stability.
Fig. 5. Pedigree of patient. There is no family history of cancer (black arrow indicates the patient).
Sudden cardiac death
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The Amsterdam criteria, the most widely used diagnostic cri-
teria for HNPCC, have the following requirements: 1) there 
should be 3 or more family members with histologically veri-
fied colorectal cancer, 2) with 1 member being a first-degree 
relative of the other two, 3) at least 1 case should have been 
diagnosed before the age of 50 years, and 4) 2 or more genera-
tions should be involved.
6 
Most patients with clinically diagnosed HNPCC will have 
germline MMR gene mutations. Although identification of 
patients with germline MMR gene mutations in the absence 
of a family history is important, most young colorectal cancer 
patients without a family history of HNPCC are unlikely to 
have germline MMR gene mutations.
5
Both HNPCC and YSCC are considered to arise through 
the mutator phenotype genetic pathway of colorectal carcino-
genesis, although YSCC may also be caused by hypermethyl-
ation of the MMR gene MLH1 instead of gene mutation it-
self.
4 
Several observations have suggested that chromosome 14 
could play an important role in microsatellite stable (MSS) 
colon carcinogenesis. As loss of chromosome 14 is more fre-
quent in aggressive tumors and in young patients, this gene 
location is likely responsible for tumor aggressiveness and he-
reditary predisposition.
7
We reported this case as an YSCC because the patient had 
neither family history of colon cancer nor any other malig-
nancy, and showed MSS without any germline abnormality. 
He had no risk factors such as inflammatory bowel disease or 
multiple colon polyps. 
YSCC also presents features similar to adult colorectal can-
cer, such as abdominal pain, altered bowel habits, weight loss, 
and rectal bleeding.
1 However, young patients present with 
more advanced-stage disease at diagnosis compared with old-
er patients. This may be because of delayed diagnosis and 
poorer pathological findings.
3 In young patients who develop 
colorectal carcinoma but have no known predisposing genetic 
risk factors, late diagnosis may result from the clinician’s fail-
ure to consider the possibility of malignant disease in the dif-
ferential diagnosis.
4
Another distinct feature of YSCC is its pathological charac-
teristics. It has a higher proportion of patients with multiple 
nodal metastasis, distant metastasis, and poorly differentiated 
tumors. YSCC also shows aggressive tumor biology, including 
a mucinous component, signet-ring cell carcinoma, and peri-
neural, vascular, and lymphatic invasion. 
Mucinous adenocarcinoma is a distinct subgroup of adeno-
carcinoma and comprises about 10% to 15% of all colorectal 
carcinomas.
8 However, an average of 28% of the lesions found 
in younger patients constituted mucinous tumors compared 
with an average of 5% for adults with colorectal carcinoma.
9
Mucinous adenocarcinoma shows higher frequencies of 
poor differentiation, advanced tumor stage, loss of MMR ex-
pression, and increased MUC2 expression compared with 
non-mucinous adenocarcinoma. These discrepancies might 
vary across different subgroups of colorectal cancer patients. 
According to a recent report, HNPCC patients showed a sim-
ilar incidence of loss of MMR expression, and YSCC patients 
showed a similar proportion of advanced tumor stage be-
tween mucinous and non-mucinous adenocarcinoma. In ad-
dition, the tumor locations of mucinous adenocarcinoma are 
significantly different between HNPCC (predominantly in 
the right colon) and YSCC (predominantly in the left colon 
and rectum).
8
The diagnostic and treatment tools for YSCC are same as 
those used for adult colon cancer. However, a report suggest-
ed that exploratory laparotomy yields a higher proportion of 
diagnostic result for colorectal carcinoma in young patients 
than in adults. Early colonoscopy is less frequently performed 
in young patients than in older patients.
1 Our case was also 
initially misdiagnosed as simple enteritis without any study 
during the first one month even though presenting significant 
symptoms. 
In a review of young-age colon cancer, studies comparing 
stage-for-stage survival found that young patients with Dukes’ 
stage A or B tumors appear to have better survival than older 
patients with similar-stage disease. Young patients with 
Dukes’ C or D lesions do the same or worse than older pa-
tients with the same disease stages.
3 A large cohort study 
found that young patients showed poor outcome despite the 
similarity of their treatment to the standard therapy for adult 
colorectal carcinoma,
10 reflecting the preponderance of ad-
vanced-stage disease in young patients. Other factors for the 
outcome besides advanced-stage were incomplete resection, 
mucinous histology and proportion of signet ring cells.
1
A prospective national cohort study following standardized 
total mesorectal excision for rectal cancer in patients aged less 
than 40 also showed considerably lower survival rate. The au-
thors suggested that biologically more aggressive cancer rath-
er than diagnostic delay seemed to account for the advanced 
stage at the time of diagnosis, leading to poor survival rates. 
Thus, age may be a significant and independent prognostic 
factor determining metastasis and survival in rectal cancer. 
Patients younger than 40 years of age had 5 times higher risk 
of metastasis and 6 times higher risk of death compared with 
patients between 40 and 44 years of age. The youngest rectal 
cancer patients seem to have additional negative prognostic 
factors, not related to histopathologic findings or tumor 
stage.
11 
In conclusion, we reported a case of a 19-year-old male pa-
tient with colon obstruction due to sporadic colon cancer with MY Chung et al. 
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a mucinous histology. He had absolutely no predisposing con-
ditions. His cancer diagnosis was delayed by the physician’s 
failure to consider malignancy in the differential diagnosis. 
Therefore, even in low-risk young patients, symptoms such as 
unexplained abdominal pain, rectal bleeding, or changes in 
bowel habits should be considered representative of signifi-
cant colorectal lesions. This case warrants increased aware-
ness and aggressive pursuit of symptoms in young patients 
without any risk factors.
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